Enter a job title or keyword

Vice President, Market Access


Job Location:

New York City, NY - USA

Monthly Salary: Not provided by the employer
Posted: 31 July 2026 (30+ days ago)
Application Deadline: 28 October 2026
Vacancies: 1 Vacancy

Job Summary

Your mission
Summary
We are seeking an accomplished and entrepreneurial Vice President Market Access to build and lead the companys U.S. Market Access organization as we prepare for the anticipated launch of vidofludimus calcium for the treatment of relapsing multiple sclerosis (RMS). The ideal candidate brings deep experience in the multiple sclerosis marketplace established relationships across national and regional payers specialty pharmacies and key health systems and a proven track record of building high-performing Market Access organizations in preparation for launch.

You must be a highly strategic leader who has successfully led one or more multiple sclerosis product launches and understands how payer strategy pricing reimbursement contracting distribution and field market access capabilities work together to maximize patient access and commercial success. As a member of the Commercial Leadership Team you will help shape Immunics overall commercialization strategy while building a best-in-class Market Access organization capable of supporting long-term commercial growth.

Responsibilities
  • Lead U.S. Market Access strategy and organization build for vidofludimus calciums launch covering pricing contracting reimbursement and distribution
  • Develop integrated access strategies spanning Commercial Medicare Medicaid VA DoD and other government channels
  • Own national payer strategy negotiating with health plans PBMs IDNs health systems and specialty pharmacies
  • Build payer value propositions using clinical economic and real-world evidence to drive favorable formulary coverage
  • Set pricing strategy gross-to-net assumptions and specialty pharmacy/trade/distribution frameworks ensuring launch-ready operations
  • Partner with Medical Affairs/HEOR on payer evidence strategy AMCP dossiers and value communication; support post-launch evidence generation
  • Serve on Commercial Leadership Team coordinating with Marketing Sales Medical Regulatory Finance Legal and Supply Chain on launch readiness
  • Design and build the Market Access org structure capabilities and metrics across Payer Strategy Marketing Pricing/Contracting Trade Analytics and Excellence functions
  • Recruit and lead a field Market Access team: National Federal and Regional Account Managers plus Field Reimbursement Managers
  • Set field deployment strategy (territories hiring training incentives) and ensure tight collaboration with Sales and Medical Affairs to maximize adoption

Your profile
  • Bachelors degree required; MBA PharmD MPH or other advanced degree preferred.
  • 15 years of progressive leadership experience within the pharmaceutical or biotechnology industry.
  • Demonstrated success leading U.S. Market Access organizations for specialty pharmaceutical products.
  • Direct experience leading the U.S. Market Access strategy for one or more multiple sclerosis product launches is strongly preferred.
  • Candidates who have played a significant leadership role in the commercialization of successful MS therapies will be strongly favored.
  • Deep understanding of the competitive dynamics payer landscape specialty pharmacy networks treatment centers and reimbursement environment within multiple sclerosis as well as negotiating with commercial payers PBMs Medicare Part D plans federal healthcare systems specialty pharmacies and integrated health systems.
  • Demonstrated success building and leading field-based Market Access organizations; experience building commercial infrastructure within an emerging biotechnology company or first-launch organization strongly preferred.
About us
Immunic is a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases. The companys lead program vidofludimus calcium is currently in phase 3 clinical trials for the treatment of relapsing multiple sclerosis with therapeutic activity shown in phase 2 clinical trials in relapsing-remitting multiple sclerosis progressive multiple sclerosis and other diseases. The development pipeline also includes earlier-stage programs addressing neurodegenerative chronic inflammatory and autoimmune-related diseases. For further information please visit: .

Required Experience:

Exec


About Company

Company Logo

Immunic Therapeutics is a dynamic biotechnology company with a pipeline of selective, orally available immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Currently, three small molecule product candidates are in various stages of clinical developme ... View more

View Profile View Profile